Viewing Study NCT01966367


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-05-27 @ 1:49 PM
Study NCT ID: NCT01966367
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-14
First Post: 2013-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
Sponsor: Diane George
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bone Marrow Failure Syndrome View
None Severe Aplastic Anemia View
None Severe Congenital Neutropenia View
None Amegakaryocytic Thrombocytopenia View
None Diamond-Blackfan Anemia View
None Schwachman Diamond Syndrome View
None Primary Immunodeficiency Syndromes View
None Acquired Immunodeficiency Syndromes View
None Histiocytic Syndrome View
None Familial Hemophagocytic Lymphocytosis View
None Lymphohistiocytosis View
None Macrophage Activation Syndrome View
None Langerhans Cell Histiocytosis (LCH) View
None Hemoglobinopathies View
None Sickle Cell Disease View
None Sickle Cell-beta-thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unrelated donor transplant View
None Haploidentical donor transplant View
None Peripheral blood stem cell transplantation View
None CD34+ selection View
None Non-malignant disease View
None Bone marrow failure syndrome View
None Severe Aplastic Anemia View
None Severe Congenital Neutropenia View
None Amegakaryocytic Thrombocytopenia View
None Diamond-Blackfan Anemia View
None Schwachman Diamond Syndrome View
None Primary Immunodeficiency Syndrome View
None Acquired Immunodeficiency Syndrome View
None Histiocytic Syndrome View
None Familial Hemophagocytic Lymphocytosis View
None Lymphohistiocytosis View
None Macrophage Activation Syndrome View
None Langerhans Cell Histiocytosis (LCH) View
None Hemoglobinopathies View
None Sickle Cell Disease View
None Sickle Cell-beta-thalassemia View